Compare IBEX & BBNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IBEX | BBNX |
|---|---|---|
| Founded | 2017 | 2015 |
| Country | United States | United States |
| Employees | N/A | 423 |
| Industry | EDP Services | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 489.1M | 560.5M |
| IPO Year | 2017 | N/A |
| Metric | IBEX | BBNX |
|---|---|---|
| Price | $29.00 | $11.78 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 11 |
| Target Price | ★ $35.00 | $26.73 |
| AVG Volume (30 Days) | 159.0K | ★ 1.2M |
| Earning Date | 05-18-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 28.26 | N/A |
| EPS | ★ 1.65 | N/A |
| Revenue | ★ $558,273,000.00 | N/A |
| Revenue This Year | $13.14 | $35.03 |
| Revenue Next Year | $5.67 | $33.24 |
| P/E Ratio | $17.62 | ★ N/A |
| Revenue Growth | ★ 9.77 | N/A |
| 52 Week Low | $21.64 | $8.89 |
| 52 Week High | $42.99 | $32.71 |
| Indicator | IBEX | BBNX |
|---|---|---|
| Relative Strength Index (RSI) | 32.64 | 26.57 |
| Support Level | $27.70 | N/A |
| Resistance Level | $29.10 | $15.64 |
| Average True Range (ATR) | 1.06 | 0.98 |
| MACD | 0.09 | 0.24 |
| Stochastic Oscillator | 41.24 | 13.56 |
IBEX Ltd delivers innovative business process outsourcing (BPO), smart digital marketing, online acquisition technology, and end-to-end customer engagement solutions to help companies acquire, engage, and retain valuable customers. It is an end-to-end provider of technology-enabled customer lifecycle experience (CLX) solutions to optimize customer acquisition, engagement, expansion, and experience for its clients. IBEX operates through the Business process outsourcing segment. Its services cover three areas: Digital and omni-channel Customer Experience (ibex Connect), Digital Marketing and E-Commerce (ibex Digital) and Digital CX surveys and analytics (ibex CX). It caters to a broad range of industries, such as telecommunications, cable, financial services, and healthcare.
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet.